Acute ischaemic stroke

British Medical Journal

Volumn 320, Issue 7236, 2000, Pages 692-696

  Gubitz, Gord ^a   Sandercock, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN;

AGE; BLOOD CLOT LYSIS; BLOOD PRESSURE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CONSTIPATION; DEPENDENT PERSONALITY DISORDER; DYSPEPSIA; HUMAN; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; SYMPTOM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CEREBROVASCULAR ACCIDENT; EVIDENCE-BASED MEDICINE; HEMATOMA, SUBDURAL; HUMANS; REHABILITATION CENTERS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0034635820     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. 1 Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull WHO 1976;54:541-53.
2. 2 Bonita R. Epidemiology of stroke. Lancet 1992;339:342-4.
3. 3 Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire community stroke project, 1981-1986. 1. Methodology, demography and incident cases of first ever stroke. J Neurol Neurosurg Psychiatry 1988;51:1373-80.
4. 4 Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire community stroke projet, 1981-1986. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53:16-22.
5. 5 Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire community stroke project. J Neurol Neurosurg Psychiatry 1990;53:824-9.
6. 6 Wade DT. Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry 1987;50:177-82.
7. 7 Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Library. Issue 3. Oxford: Update Software, 1999.
8. 8 Stegmayr B, Asplund K, Hulter-Asberg K, Norrving B, Peltonen M, Terent A, et al. Stroke units in their natural habitat: can results of randomized trials be reproduced in routine clinical practice? Stroke 1999;30:709-14.
9. 9 Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for Acute Ischaemic Stroke. Cochrane Library. Issue 3. Oxford: Update Software, 1999.
10. 10 Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999;340:1781-7.
11. 11 Sudlow C, Baigent C, Gubitz G, Sandercock P, Lip GYH. Stroke: secondary prevention. Clinical Evidence 1999;2:113-27.
12. 12 Sandercock P, Gubitz G, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Library. Issue 3. Oxford: Update Software, 1999.
13. 13 CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349:1641-9.
14. 14 International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomised trial of aspirin, heparin, both or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
15. 15 Antiplatelet Trialist's Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
16. 16 Slattery J, Warlow CP, Shorrock CJ, Langman MJS. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995;37:509-11.
17. 17 Sandercock P, Gubitz G, Counsell C, Signorini D. Anticoagulants for acute ischaemic stroke. Cochrane Library. Issue 3. Oxford: Update Sofware, 1999.
18. 18 Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke. Cochrane Library. Issue 3. Oxford: Update Software, 1999.
19. 19 Wahlgren NG, MacMahon DG, DeKeyser J, Ingredavik B, Ryman, T. Intravenous nimedipine west European stroke trial (INWEST) of nimedipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994;4:204-10.
20. 20 Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JRA. Low dose beta blockade in acute stroke (BEST trial): an evaluation. BMJ 1988;296: 737-41.
21. 21 Mohr JP, Orgogozo JM, Harrison MJG, Hennerici M, Wahlgren NG, Gelmers JH, et al. Meta-analysis of oral nimodipine trials in acute ischaemic stroke. Cerebrovasc Dis 1994;4:197-203.
22. 22 Horn J, Orgogozo JM, Limburg M. Review on calcium antagonists in ischaemic stroke; mortality data. Cerebrovasc Dis 1998;8(suppl 4):27.
23. 23 Rodgers A, MacMahon S, Gamble G. Blood pressure and risk of stroke patients with cerebrovascular disease. BMJ 1996;313:147.
24. 24 Bath F, Bath P. What is the correct management of blood pressure in acute stroke? The Blood Pressure in Acute Stroke Collaboration. Cerebrovasc Dis 1997;7:205-13.
25. 25 Schrader J, Rothemeyer M, Luders S, Kollmann K. Hypertension and stroke - rationale behind the ACCESS trial. Basic Research in Cardiology 1998;93(suppl 2):69-78.
26. 26 Prasad K, Shrivastava A. Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Library. Issue 3. Oxford: Update Software, 1999.
27. 27 Hankey G, Hon C. Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomised trials. Stroke 1997;28:2126-32.
28. 28 Treatment of primary intracerebral haemorrhage. In: Warlow CP, Dennis MS, van Gijn J, et al, eds. Stroke: a practical guide to management. Oxford: Blackwell Science, 1996:435.